Health Technology Suzuken Co., Ltd. Business Summary
Suzuken Co., Ltd. engages in the pharmaceutical business. It operates through the following segments: Pharmaceutical Wholesale, Pharmaceutical Manufacturing, Insurance Pharmacy, and Healthcare-related Services. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic reagents, medical equipment, and supplies. The Pharmaceutical Manufacturing segment manufactures and sells pharmaceuticals and diagnostic reagents. The Insurance Pharmacy segment prepares medicines based on prescriptions from medical institutions. The Healthcare-related Services segment includes medical book sales, medical device manufacturing, and drug transportation businesses. The company was founded by Kenzo Suzuki on November 13, 1932 and is headquartered in Nagoya, Japan.
Financial Highlights
Mar 2022
JPY USD Revenue 2,232.77B 19,869.36M Gross Profit 160,994M 1,432.67M Operating income 13,778M 122.60M Income before tax 22,484M 200.08M Net income 14,394M 128.09M EBITDA 23,797M 211.76M Diluted EPS 163.18 1.45 Dividends Per Share 72 0.64 Total Assets 1,141.71B 9,406.52M Total liabilities 723,653M 5,962.12M Total equity 417,687M 3,441.29M Operating cash flow 9,520M 84.71M Currency in JPY Currency in USD
Historical Data Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Revenue
2,124.01B
2,132.34B
2,213.53B
2,128.47B
2,232.77B
Gross Profit
187,512M
189,295M
194,124M
157,841M
160,994M
Operating income
19,737M
27,229M
32,572M
9,158M
13,778M
Income before tax
28,766M
45,479M
41,808M
12,557M
22,484M
Net income
18,821M
30,205M
28,213M
7,896M
14,394M
EBITDA
31,800M
38,788M
43,998M
19,466M
23,797M
Diluted EPS
198.21
322.72
310.26
88.51
163.18
Dividends Per Share
64
69
72
72
72
Total Assets
1,173.32B
1,189.23B
1,112.50B
1,114.42B
1,141.71B
Total liabilities
766,896M
787,611M
699,796M
696,508M
723,653M
Total equity
405,752M
400,775M
411,839M
417,048M
417,687M
Operating cash flow
98,066M
41,751M
-25,817M
15,602M
9,520M
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Revenue
19,164.21M
19,228.56M
20,358.85M
20,069.11M
19,869.36M
Gross Profit
1,691.85M
1,706.98M
1,785.44M
1,488.25M
1,432.67M
Operating income
178.07M
245.53M
299.57M
86.34M
122.60M
Income before tax
259.54M
410.10M
384.52M
118.39M
200.08M
Net income
169.81M
272.37M
259.48M
74.45M
128.09M
EBITDA
286.91M
349.77M
404.66M
183.54M
211.76M
Diluted EPS
1.78
2.91
2.85
0.83
1.45
Dividends Per Share
0.57
0.62
0.66
0.67
0.64
Total Assets
11,032.68M
10,744.34M
10,305.28M
10,085.25M
9,406.52M
Total liabilities
7,211.05M
7,115.78M
6,482.29M
6,303.24M
5,962.12M
Total equity
3,815.25M
3,620.86M
3,814.91M
3,774.19M
3,441.29M
Operating cash flow
884.81M
376.49M
-237.45M
147.10M
84.71M
Valuation Measures
Mar 2022
PER 22.24 ROA 1.27% ROE 3.44% Operating margin 0.61% Profit margin 0.64%
Key executives
President & Representative Director:
Shigeru Asano
Executive Officer & Compliance Manager:
Asako Tomita
Manager-Business Administration:
Masahiro Hamanaka
Director & Senior Managing Executive Officer:
Hisashi Tamura
Director, Head-Internal Control & Audit:
Chie Takahashi Shareholders
Suzuken Co., Ltd. (14.8%)
Silchester International Investors LLP (9.2%)
Shionogi & Co., Ltd. (3.1%)
BESSHO YOSHIKI (2.9%)
IZAWA HISAYO (2.3%)
Nomura Asset Management Co., Ltd. (2.2%)
NAGAI CHIKA (2.2%)
BESSHO MASAKI (2.1%)
Kopernik Global Investors LLC (2.0%)
Suzuken Group Employee Stock Ownership Plan (1.8%)
Contact Details Website: http://www.suzuken.co.jp Address:
8 Higashi Kataha-machi,
Higashi-Ku,
Nagoya,
461-8701,
Japan
Phone:
+81.52.961.2331
Related Companies
Suzuken Co. Ltd. /Fukushima Koen Bus/
S.D. Collabo Co., Ltd.
S-Care Mate Co., Ltd.
Life Medicom Co., Ltd.
Suzuken Restricted Stock Compensation Plan
Embrace Co., Ltd.
Suzuken Trust
Suzuken Medical Information Bank KK
Ryomo Iyakuhin KK
Nakano Yakuhin KK
Medicis KK
Suzuken Okinawa Yakuhin Co., Ltd.
Chugoku Farmacy KK
Astis Co., Ltd.
Akiyama Butsuryu Service KK
Sanki Wellbe KK
Owl Chozai KK
Suzuken Logicom Corp.
Pfercos Co., Ltd.
Suzuken Iwate Co., Ltd.
Kenzmedico Co., Ltd.
Sanki Corp.
Akiyama, Inc.
Pfercos KK
Jingu Yakuhin KK
Omori Yakuhin Co. Ltd.
Shoyaku Co., Ltd.
Okinawa Yakuhin
Sanki Co., Ltd. /Medical/
Suzuken Group Employee Stock Ownership Plan
Competitors
Sienna Biopharmaceuticals, Inc.
Copyright © 2022 FactSet Research Systems Inc. All rights reserved.
Last Updated on 16 Aug, 2022
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter
Free access for everyone - Sep. 30
Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
Cookie Policy
to learn how you can update your cookie settings.
Accept & Continue
Close